2Scheuemlan O, Nofech-Moses Y, Rachmel A, et al. Successful Treatment of Antiepileptic Drug Intravenous Immune Globulin. E14-E16. Hypersensitivity Syndrome With Pediatrics, 2001, 107 ( 1 ):.
3Prais D, Straussberg R, Amir J, et al. Treatment of Anticonvulsant Hypersensitivity Syndrome with Intravenous Immunoglobulins and Corticosteroids. J Child Neurol,2006,21 (5) :380-384.
4Rzany B, Correia O, Kelly JP, et al. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions. Lancet, 1999 ,353 (10) :2190-2194.
5Ghislain PD,Roujeau JC. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol Online J,2002 ,8(1 ) :5-10.
6Gogtay NJ, Bavdekar SB, Kshirsagar NA. Anticonvulsant hypersensitivity syndrome : a review. Expert Opin Drug Saf, 2005,4 (3) :571-581.
7Bohan KH, Mansuri TF, Wilson NM. Anticonvulsant hypersensitivity syndrome: implications for pharmaceutical care. Pharmacotherapy,2007 ,27(10) : 1425-1439.
8Mockenhaupt M,Messenheimer J,Tennis P,et al. Risk of Stevens- Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics. Neurology,2005,64(7) :1134-1138.
9MOHAMED R, NADEEM H. Anticonvulsant Hypersensitivity Syndrome From Addition of Lamotrigine to Divalproex . Am J Psychiatry, 2005,162 ( 9 ) : 1021-1024.
10Arif H, Buchsbaum R, Weintraub D, et al. Comparison and predictots of rash associated with 15 antiepileptic drugs. Neurology, 2007,68 (20) : 1701-1709.
